Year: 2025
Type: article
Abstract: This review highlights the mechanisms of action and current evidence on the effectiveness of inositol for the treatment of reproductive disorders.The results of the studies showed that inositol plays an important role in the functioning of the reproductive system in both women and men. In women, myo-inositol (MI) acts as a second messenger of follicle-stimulating hormone in signaling pathways that regulate the proliferation and maturation of granulosa cells. MI also affects the production of anti-MГјllerian hormone, which plays a key role in the maturation of the egg, its passage through the fallopian tubes and the formation of high-quality embryos. The ovaries have a specific ratio of MI to D-chiro-inositol (DCI), which ensures their normal functioning. Excess DCI can impair the quality of oocytes and blastocysts, so its level needs to be strictly regulated.In men, DCI affects steroidogenesis, stimulating the synthesis of androgens by Leydig cells of the testicles. It also regulates the expression of the aromatase enzyme, which leads to a decrease in estrogen synthesis. A change in the MI:DCI ratio can cause hormonal imbalance, characteristic of conditions such as polycystic ovary syndrome, female and male infertility. The use of MI and DCI in a ratio of 40:1 demonstrates the highest effectiveness in reducing all manifestations of polycystic ovary syndrome. This combination is considered first-line therapy for women with polycystic ovary syndrome and excess body weight, as it contributes to the normalization of metabolic indicators and improvement of clinical outcomes. The effectiveness of this combination of inositol stereoisomers is due to their synergistic effect: DCI reduces peripheral hyperinsulinemia, while MI restores ovulatory function. As a result, combination therapy reduces the risk of metabolic syndrome, improves hormonal balance and increases insulin sensitivity. Due to high efficacy, good tolerability, minimal side effects and low toxicity, inositols can be safely and widely used in these reproductive disorders.
Source: Reproductive Endocrinology
Authors: L.K. Sokolova, Y.B. Belchina
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7168271948
